- Home
- PGNY
PGNY
Progyny Inc.
as 01-21-2025 3:41pm EST
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.2B | IPO Year: | 2019 |
| Target Price: | $19.17 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.60 | EPS Growth: | 17.45 |
| 52 Week Low/High: | $13.39 - $42.08 | Next Earning Date: | 02-25-2025 |
| Revenue: | $1,138,730,000 | Revenue Growth: | 10.24% |
| Revenue Growth (this year): | 7.2% | Revenue Growth (next year): | 1.11% |
Stock Insider Trading Activity of Progyny Inc. (PGNY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Schlanger David J | PGNY | Executive Chairman | Dec 26 '24 | Buy | $14.68 | 150,000 | $2,202,330.00 | 228,269 | |
| Anevski Peter | PGNY | CHIEF EXECUTIVE OFFICER | Dec 23 '24 | Buy | $14.48 | 209,500 | $3,034,083.75 | 441,463 |
Latest Progyny Inc. News
PGNY Breaking Stock News: Dive into PGNY Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
Argus Research
7 days ago
PGNY: Raising target price to $16.00
GlobeNewswire
9 days ago
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
PR Newswire
9 days ago
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
MT Newswires
15 days ago
Progyny Pick of the Week at Smart Insider Following CEO, Executive Chair Stock Purchases
Barrons.com
19 days ago
Progyny Stock Saw Big Buys From the CEO and a Former CEO
Simply Wall St.
24 days ago
Progyny CEO & Director Acquires 136% More Stock
Insider Monkey
a month ago
Progyny, Inc. (PGNY): A Bull Case Theory
Compare PGNY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PGNY Progyny Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.